Methods for treating heart failure using beta-ARKnt peptide
AssigneeTemple University of the Commonwealth System of Higher Education
InventorsWalter J. Koch, Sarah M. Schumacher-Bass
Life of this patent
Estimating the term…
Abstract
This invention is generally related to novel compositions for treating or preventing heart failure. Specifically, the disclosure provides a composition comprising an amino-terminal domain of Beta.adrenergic receptor kinase-1 (Beta.ARKnt) peptide, or a nucleic acid encoding Beta.ARKnt. Further disclosed are methods of using the compositions for treating or preventing heart failure in a subject or for altering Beta.-adrenergic receptor (Beta.AR) density in a subject.
Claims3
A method for treating or preventing heart failure in a subject, the method comprising administering an effective amount of a composition comprising a nucleic acid encoding a beta-adrenergic receptor kinase N-terminal (βARKnt) peptide,
- wherein the βARKnt peptide comprises an amino acid sequence at least 90% homologous to SEQ ID NO:
- 1.
Dependencies are inferred from the claim text.